ChargePoint Acquires Assets of Forac - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

ChargePoint Acquires Assets of Forac

ChargePoint Technology, a UK-based manufacturer and supplier of precision containment valves to the pharmaceutical and chemical industries, announced that it has acquired the assets of Forac Limited, a key business in its supply chain.

Under the deal, ChargePoint will have access to a compact pneumatic actuator used to open and close the isolation valves that feature in production processes used by the pharmaceutical, food and fuel industries. No financial terms were disclosed.

Forac will relocate its plant and stock from a base in Shoreham-by-Sea, West Sussex to ChargePoint’s manufacturing plant in Speke, Merseyside. Founder and managing director of Forac Adam Bunyard has joined ChargePoint as part of the deal.

ChargePoint’s containment valves are used for the safe and sterile handling of powders in manufacturing processes, for example when making drugs in tablet form. The valves enable safe transferring of powders from one vessel to another during the production process. By minimizing dust emissions, they are specified to prevent cross-contamination and protect operators from exposure to potent substances.

Source: ChargePoint 


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications

Click here